For: | Liang JH, Lin Y, Ouyang T, Tang W, Huang Y, Ye W, Zhao JY, Wang ZN, Ma CC. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine. World J Gastroenterol 2019; 25(25): 3218-3230 [PMID: 31333313 DOI: 10.3748/wjg.v25.i25.3218] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i25/3218.htm |
Number | Citing Articles |
1 |
Yan Zhao, Changchun Ma, Rongzhi Cai, Lijing Xin, Yongsheng Li, Lixin Ke, Wei Ye, Ting Ouyang, Jiahao Liang, Renhua Wu, Yan Lin. NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-46837-0
|
2 |
Bin Zang, Wen Wang, Yiqian Wang, Pengfei Li, Tian Xia, Xiaolong Liu, Di Chen, Hai-long Piao, Huan Qi, Yegang Ma. Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.721990
|
3 |
Ziqi Yue, Junmei Wang, Rui Hu, Quanhui Peng, Hongrui Guo, Huawei Zou, Jianxin Xiao, Yahui Jiang, Zhisheng Wang. Effects of Glutamine or Glucose Deprivation on Inflammation and Tight Junction Disruption in Yak Rumen Epithelial Cells. Animals 2024; 14(22): 3232 doi: 10.3390/ani14223232
|
4 |
Wei Ye, Yan Lin, Tedros Bezabeh, Changchun Ma, Jiahao Liang, Jiayun Zhao, Ting Ouyang, Wan Tang, Renhua Wu. 1H NMR‐based metabolomics of paired esophageal tumor tissues and serum samples identifies specific serum biomarkers for esophageal cancer. NMR in Biomedicine 2021; 34(6) doi: 10.1002/nbm.4505
|
5 |
Marie‐France Penet, Raj Kumar Sharma, Santosh Bharti, Noriko Mori, Dmitri Artemov, Zaver M. Bhujwalla. Cancer insights from magnetic resonance spectroscopy of cells and excised tumors. NMR in Biomedicine 2023; 36(4) doi: 10.1002/nbm.4724
|
6 |
Susan Costantini, Alfredo Budillon. Metabolomics Perspectives. 2022; : 553 doi: 10.1016/B978-0-323-85062-9.00016-7
|
7 |
Jinhui Zhao, Xinshu Zhao, Jiaying Yu, Siqi Gao, Mingjia Zhang, Tongshu Yang, Liyan Liu. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma. Analytica Chimica Acta 2022; 1220: 340038 doi: 10.1016/j.aca.2022.340038
|
8 |
Min Yang, Dihua Jiang, Longfei Huang, Tao Zhang, Wenfen Guo, Wenyan Lin, Jiali Zhao, Yunsheng Wei, Lang Peng, Yong-Jia Hao, Ying Zhou. Multi-target regulatory effects of rhaponticin in a rat model of hepatic fibrosis revealed by non-targeted metabolomics. Frontiers in Pharmacology 2025; 15 doi: 10.3389/fphar.2024.1505309
|
9 |
Katherine Huang, Natalie Thomas, Paul R. Gooley, Christopher W. Armstrong. Systematic Review of NMR-Based Metabolomics Practices in Human Disease Research. Metabolites 2022; 12(10): 963 doi: 10.3390/metabo12100963
|
10 |
Marie-France Penet, Zaver M. Bhujwalla. Encyclopedia of Biophysics. 2022; : 1 doi: 10.1007/978-3-642-35943-9_10097-1
|
11 |
Chao Zhao, Hui Han, Yushuang Tian, Guangjin Qu, Yingying Xu, Yihan Wang, Lili Shi. Identification of genome-wide copy number variation-driven subtypes for the treatment and prognostic prediction of esophageal carcinoma. Heliyon 2024; 10(19): e38011 doi: 10.1016/j.heliyon.2024.e38011
|
12 |
Yunjie Li, Fengqiong Hu, Jie Deng, Xin Huang, Chunyan Zhou, Mengxue Wu, Dong Duan. Proteomic analysis of radioiodine‑refractory differentiated thyroid cancer identifies CHI3L1 upregulation in association with dysfunction of the sodium‑iodine symporter. Oncology Letters 2022; 25(1) doi: 10.3892/ol.2022.13622
|
13 |
Yanling Sun, Xinchang Zheng, Guoliang Wang, Yibo Wang, Xiaoning Chen, Jiani Sun, Zhuang Xiong, Sisi Zhang, Tianyi Wang, Zhuojing Fan, Congfan Bu, Yiming Bao, Wenming Zhao. MACdb: A Curated Knowledgebase for Metabolic Associations across Human Cancers. Molecular Cancer Research 2023; 21(7): 691 doi: 10.1158/1541-7786.MCR-22-0909
|
14 |
Rongzhi Cai, LiXin Ke, Yan Zhao, Jiayun Zhao, Huanian Zhang, Peie Zheng, Lijing Xin, Changchun Ma, Yan Lin. NMR‐based metabolomics combined with metabolic pathway analysis reveals metabolic heterogeneity of colorectal cancer tissue at different anatomical locations and stages. International Journal of Cancer 2024; doi: 10.1002/ijc.35273
|
15 |
Ting Ouyang, Changchun Ma, Yan Zhao, Wei Ye, Jiayun Zhao, Rongzhi Cai, Huanian Zhang, Peie Zheng, Yan Lin. 1H NMR-based metabolomics of paired tissue, serum and urine samples reveals an optimized panel of biofluids metabolic biomarkers for esophageal cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1082841
|
16 |
Jieyin Deng, Silin Wu, Ye Huang, Yi Deng, Ke Yu. Esophageal cancer risk is influenced by genetically determined blood metabolites. Medicine 2024; 103(43): e40122 doi: 10.1097/MD.0000000000040122
|